Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Capital Employed (2016)

Historic Return on Capital Employed for Tenax Therapeutics (TENX) over the last 4 years, with Q4 2016 value amounting to 1.8%.

  • Tenax Therapeutics' Return on Capital Employed changed N/A to 1.8% in Q4 2016 from the same period last year, while for Dec 2016 it was 1.8%, marking a year-over-year change of. This contributed to the annual value of 2.96% for FY2013, which is 173200.0% up from last year.
  • Latest data reveals that Tenax Therapeutics reported Return on Capital Employed of 1.8% as of Q4 2016.
  • Tenax Therapeutics' Return on Capital Employed's 5-year high stood at 99.31% during Q3 2012, with a 5-year trough of 64.89% in Q2 2013.
  • In the last 3 years, Tenax Therapeutics' Return on Capital Employed had a median value of 13.88% in 2012 and averaged 17.72%.
  • As far as peak fluctuations go, Tenax Therapeutics' Return on Capital Employed soared by 970700bps in 2012, and later tumbled by -979800bps in 2013.
  • Tenax Therapeutics' Return on Capital Employed (Quarter) stood at 21.62% in 2012, then plummeted by -400bps to 64.89% in 2013, then soared by 97bps to 1.8% in 2016.
  • Its Return on Capital Employed stands at 1.8% for Q4 2016, versus 1.68% for Q3 2016 and 64.89% for Q2 2013.